abstract |
The invention relates to fused heterocyclic polycyclic compounds of the formula (I), their use as PAF (platelet aggregation factor) antogonists, antihistamines and / or anti-inflammatory agents, methods of making the same, and compositions. pharmaceuticals comprising said compounds. |